Exelixis
EXEL
#1750
Rank
$11.98 B
Marketcap
$44.52
Share price
1.00%
Change (1 day)
26.12%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Market capitalization of Exelixis (EXEL)

Market cap: $11.98 Billion USD

As of January 2026 Exelixis has a market cap of $11.98 Billion USD. This makes Exelixis the world's 1750th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Exelixis from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026$11.98 B-3.72%
2025$12.44 B28.92%
2024$9.65 B29.42%
2023$7.46 B44.19%
2022$5.17 B-10.54%
2021$5.78 B-7.11%
2020$6.22 B16.3%
2019$5.35 B-9.24%
2018$5.89 B-34.42%
2017$8.99 B108.06%
2016$4.32 B236.22%
2015$1.28 B355.78%
2014$0.28 B-75.06%
2013$1.13 B34.75%
2012$0.83 B30.78%
2011$0.64 B-28.46%
2010$0.89 B12.81%
2009$0.79 B50.04%
2008$0.53 B-41.36%
2007$0.90 B4.63%
2006$0.86 B9.96%
2005$0.78 B10.28%
2004$0.71 B41.74%
2003$0.50 B5.8%
2002$0.47 B-49.09%
2001$0.93 B36.54%
2000$0.68 B

End of Day market cap according to different sources

On Jan 13th, 2026 the market cap of Exelixis was reported to be:

$11.81 Billion USD
by Nasdaq info icon info icon
$11.86 Billion USD
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
GlaxoSmithKline
GSK
$101.65 B 748.22%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
$116.19 B 869.52%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
$270.98 B 2,161.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$113.64 B 848.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$175.41 B 1,363.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$516.22 B 4,207.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$143.39 B 1,096.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Curis
CRIS
$11.63 M-99.90%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
$0.52 B-95.65%๐Ÿ‡บ๐Ÿ‡ธ USA